Clinical trial
Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
NCT00533572 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer
- Lead sponsor
- Stanford University
- Phase
- Observational
- Overall status
- Terminated
- Start date
- August 31, 2007
- Completion date
- August 31, 2008
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.